|
The active form, and first metabolite of, Spironolactone. |
Canrenone
|
|
0.77 min. | 2.16 user rating |
1.07 min. | 3.0 user rating |
0.55 min. | 2.0 user rating |
1.25 min. | 0 user rating |
7.97 min. | 3.66 user rating |
Sulfonamides (except EA) | ||
---|---|---|
CA inhibitors (at PT) | Acetazolamide | |
Loop (Na-K-Cl at AL) | Furosemide# * Bumetanide * Torasemide * Etacrynic acid | |
Thiazides (Na-Cl at DCT, Calcium-sparing) | Hydrochlorothiazide# * Bendroflumethiazide * Hydroflumethiazide * Chlorothiazide * Polythiazide * Trichlormethiazide * Cyclopenthiazide * Methyclothiazide * Cyclothiazide * Mebutizide | |
Thiazide-likes (primarily DCT) | Quinethazone * Clopamide * Chlortalidone * Mefruside * Clofenamide * Metolazone * Meticrane * Xipamide * Indapamide * Clorexolone * Fenquizone | |
Potassium-sparing (at CD) | ||
ESC blockers | Amiloride# * Triamterene * Benzamil | |
Aldosterone antagonists | Spironolactone# * Eplerenone * Potassium canrenoate * Canrenone | |
Osmotic diuretics (PT, DL) | ||
Mannitol# * Urea | ||
VAs (DCT and CD) | ||
vaptans: Conivaptan * Mozavaptan * Satavaptan * Tolvaptan tetracyclines: Demeclocycline | ||
Other | ||
mercurial diuretic (Mersalyl) * Theobromine * Cicletanine | ||